Theravance Biopharma, Inc. (TBPH) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2012: $02013: $02014: $4.06M2015: $4.66M2016: $2.89M2017: $6.03M$6.03M
2012Cost of Revenue (USD)2017
Fiscal YearCost of RevenueChange YoY
2017$6.03M+108.4%
2016$2.89M-37.9%
2015$4.66M+14.8%
2014$4.06M
2013$0
2012$0